NORTH AMERICA VETERINARY MEDICINES MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA VETERINARY MEDICINES MARKET FORECAST 2019-2028

NORTH AMERICA VETERINARY MEDICINES MARKET FORECAST 2019-2028

The North America veterinary medicines market is expected to record a CAGR of 3.82%, during the forecast period of 2019 to 2028. The region’s market growth drivers include the rise in animal health expenditure and the growing need for innovative veterinary treatment options. The North America veterinary medicines market growth analysis includes the assessment of the United States and Canada. In 2019, the United States accounted for the largest share across the veterinary medicines market.

NORTH AMERICA VETERINARY MEDICINES MARKET FORECAST 2019-2028

North America Veterinary Medicines Market by Animal Type (Companion Animals, Livestock Animals) by Distribution Channel (Retail Veterinary Pharmacies, Veterinary Hospital Pharmacies) by Route of Administration (Parenteral Route, Oral Route, Topical Route) by Product (Drugs (Anti-infective, Anti-inflammatory, Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives(Antibiotics, Amino Acids)) and by Geography.

Request free sample

The North America veterinary medicines market is expected to record a CAGR of 3.82%, during the forecast period of 2019 to 2028. The region’s market growth drivers include the rise in animal health expenditure and the growing need for innovative veterinary treatment options.
North America Veterinary Medicines Market

To learn more about this report, request a free sample copy

The North America veterinary medicines market growth analysis includes the assessment of the United States and Canada. In 2019, the United States accounted for the largest share across the veterinary medicines market. Factors such as the surge in pet ownership, and the easy availability of veterinary medicine, contribute to the market growth. According to the APPA National Pet Owners Survey, 2019-2020, nearly 67% of households in the United States own a pet, thereby equating to more than 84 million homes. Likewise, the livestock animal population is continually rising, leading to an increased demand for veterinary medicine. The country’s surging animal healthcare expenditure is also instrumental in augmenting the market growth.

In 2019, according to the Companion Animal Parasite Council, more than 667,000 dogs and 64,680 cats in the United States were affected by Giardia, a microscopic parasite causing giardiasis, a diarrheal ailment. As a result, the growing incidence and prevalence of numerous medical conditions in the United States, requiring veterinary medicines, further bolster market growth. Likewise, medical conditions like arthritis are also typical among companion animals, thus, contributing to the growing demand for veterinary medicines. Therefore, such factors are anticipated to propel the market growth, over the forecast period.

Archer Daniels Midland (ADM), headquartered in the United States, is among the leading distributor and processors of agricultural products for food and animal feed. It also has additional operations in the storage and transportation of these products. In July 2020, the company announced the launch of NutriPass L, an encapsulated lysine supplement, rumen-stable, and intestinally available to cows.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • SURGING LIVESTOCK POPULATION
      • INCREASING ANIMAL HEALTHCARE EXPENDITURE
      • GROWING PET OWNERSHIP
      • RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
    •    KEY RESTRAINTS
      • STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • HIGH COST OF VACCINATIONS
      • RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  3. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  4. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  5. MARKET BY PRODUCT
    • DRUGS
    • VACCINES
    • MEDICATED FEED ADDITIVES
  6. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ARCHER DANIELS MIDLAND
    • BIOGENESIS BAGO SA
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • DECHRA PHARMACEUTICALS PLC
    • ELANCO
    • EVONIK INDUSTRIES AG (RAG STIFTUNG)
    • HESTER BIOSCIENCES LIMITED
    • INDIAN IMMUNOLOGICALS LIMITED
    • KINDRED BIOSCIENCES
    • MERCK & CO
    • NEOGEN CORPORATION
    • VETOQUINOL (SOPARFIN SCA)
    • VIRBAC SA
    • ZOETIS

TABLE LIST

TABLE 1: MARKET SNAPSHOT – VETERINARY MEDICINES

TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)

TABLE 3: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: NORTH AMERICA VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: NORTH AMERICA VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: NORTH AMERICA VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 10: NORTH AMERICA VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019

FIGURE 6: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 9: NORTH AMERICA VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 12: NORTH AMERICA VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019

FIGURE 16: NORTH AMERICA VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 20: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 21: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  2. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  3. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  4. MARKET BY PRODUCT
    • DRUGS
    • VACCINES
    • MEDICATED FEED ADDITIVES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now